Repeated exposure to a common anaesthesia drug early in life results in visual recognition memory impairment, which emerges after the first year of life and may persist long-term, according to a study from the Icahn School of Medicine at Mount Sinai and published in The British Journal of Anaesthesia.
Experimental studies in animals have shown that exposure to general anaesthesia in infancy can cause loss of cells in the central nervous system and long-term impairments in neurocognitive function. Some human epidemiological studies have shown that children who undergo more than one operation under general anaesthesia before they are four years old are at a greater risk of learning disability and other cognitive impairments.
The Mount Sinai study is among the first to address the question of whether repeated postnatal anaesthesia exposure, in and of itself, results in memory impairment in a highly translationally relevant rhesus monkey model. Rhesus monkeys at birth are at a stage of neurodevelopment that is more similar to that of human infants than are neonatal rodents; with respect to brain growth, a six-week-old rhesus monkey corresponds to a human 6 to 12 months of age. Because these kinds of controlled studies cannot be carried out in humans, it is essential to use a comparable animal model to discover if anaesthesia is affecting the brain. Unlike previous research, the study was conducted in the absence of a surgical procedure, co-morbidities that may necessitate surgical intervention, or the psychological stress associated with illness.
“The major strength of this study is its ability to separate anaesthesia exposure from surgical procedures, which is a potential complication in the studies conducted in children,” says Mark Baxter, professor in the Departments of Neuroscience and Anesthesiology at the Icahn School of Medicine at Mount Sinai. “Our results confirm that multiple anaesthesia exposures alone result in memory impairment in a highly translational animal model. Interestingly, the anaesthesia-exposed group had normal visual memory at six months of age. Visual memory impairment didn’t emerge until the second year of life, corresponding roughly to the age of three to six years old in humans.”
Specifically, the study team exposed 10 non-human primate subjects to a common paediatric anaesthetic called sevoflurane for four hours, the length of time required for a significant surgical procedure in humans. They were exposed to the anaesthetic at postnatal day 7 and then again two and four weeks later, because human data indicate that repeated anaesthesia results in a greater risk of cognitive disability relative to a single anaesthetic exposure.
Researchers evaluated the visual recognition memory of exposed subjects compared with that of healthy controls at 6-10 months of age, 12-18 months of age and again at 24-30 months of age using the visual paired comparison test, which measures memory by assessing preference for looking at a new image over a previously viewed one. They found the anaesthesia-exposed infants displayed no memory impairment when tested at 6-10 months, but demonstrated significant memory impairment (reduced time looking at the novel image) after the first year of life compared with the control group.
“Our findings are consistent with epidemiological studies that show increased risk of long-term cognitive impairments after repeated exposure to anaesthesia in infancy and early childhood, but perhaps most interestingly, we found that these deficits may emerge at later developmental stages, even when memory performance is unaffected earlier in development,” says Baxter. “Our goal is to continue this work to test possible interventions that can prevent long-term cognitive impairments after early anaesthesia exposure.”
These findings are part of a larger longitudinal study, and researchers at the Icahn School of Medicine at Mount Sinai and the Yerkes National Primate Research Center will continue to follow these study subjects behaviourally to fully characterise the length of time that cognitive and emotional changes persist and whether they resolve over time.
In December 2016, the FDA placed a warning on common anaesthetic/sedative drugs, including sevoflurane, for children under three years of age receiving prolonged (more than three hours) or repeated anaesthesia, saying that this may cause a risk of cognitive impairment.
This primate model may be used be researchers for future studies to develop a new anaesthetic agent or prophylactic treatment to counteract the impact of anaesthesia on behaviour in children. The findings also suggest that additional work is required to identify the mechanisms by which anaesthetics may cause long-term changes in central nervous system function that impact behaviour.
Article: Visual recognition memory is impaired in rhesus monkeys repeatedly exposed to sevoflurane in infancy, M. C. Alvarado, K. L. Murphy, M. G. Baxter, The British Journal of Anaesthesia, doi: 10.1093/bja/aew473, published 31 May 2017.
Source: Medical News Today